newsfilter
← Latest News
GlobeNewswire·

I-Mab Announces Publication of Givastomig Monotherapy Data in Clinical Cancer Research

Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab plus chemotherapy ROCKVILLE, MD, June 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:IMAB)